# Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.

> **NCT00246675** · NA · WITHDRAWN · sponsor: **Melbourne Health**

## Conditions studied

- Renal Impairment After Cardiac Surgery

## Interventions

- **DRUG:** Frusemide

## Key facts

- **NCT ID:** NCT00246675
- **Lead sponsor:** Melbourne Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study has ceased recruiting as Ethics approval has lapsed and the investigator availability reduced.
- **Last updated:** 2015-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00246675

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00246675, "Frusemide Infusion for the Prevention of Deterioration in Renal Function Post Cardiac Surgery.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00246675. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*